Search - tctmd.com

Displaying 1 - 20 of 158

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

News Daily News

AHA Stats Show CV Health of Americans Remains Dire

Michael O'Riordan

January 28, 2025

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

News Daily News

Just One in Five Grand Rounds Lectures Given by Women

Michael O'Riordan

January 07, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Todd Neale

September 26, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Coverage and Use of Impella and Watchman: A Tale of Four Countries

AHA Scientific Statement Takes Aim at PAD Pain

AHA Stats Show CV Health of Americans Remains Dire

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

Just One in Five Grand Rounds Lectures Given by Women

Top Endovascular News of 2024

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

AHA Celebrates a Century by Looking Back, and Forward

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content